Newborn Screening Market: Size, Share and Forecast for 2028

By | November 20, 2023


The global newborn screening market, valued at USD 1.30 billion in 2022, is forecasted to experience remarkable growth, reaching approximately USD 2.20 billion by 2028. This robust trajectory is attributed to collaborative efforts among leading companies, leveraging diverse approaches to fortify their market position.

Factors Driving Market Growth

Expanded Screening Panels One of the primary drivers fueling market expansion is the adoption of expanded screening panels. These panels encompass tests for a wider array of genetic, metabolic, and congenital disorders. By enabling early detection of conditions that might not immediately manifest symptoms, expanded panels facilitate timely intervention and treatment. This proactive approach significantly enhances long-term health outcomes for affected infants, potentially averting severe complications and developmental delays. Moreover, early detection through expanded panels can pave the way for preventive measures or lifestyle modifications, mitigating the severity or even preventing certain conditions.

Advancements in Technology and Precision Medicine The convergence of expanded panels aligns with the principles of personalized and precision medicine. By tailoring healthcare to individual needs, these advancements contribute to comprehensive care for newborns, addressing a broader spectrum of potential health concerns.

Who Will Benefit from This Report

  • Healthcare professionals involved in newborn care and diagnostics
  • Biotechnology and pharmaceutical companies specializing in newborn screening technologies
  • Government healthcare departments shaping public health policies
  • Investors and stakeholders in the healthcare sector seeking market insights

Impact of Newborn Screening Tests

The newborn screening test plays a pivotal role in identifying approximately 30 metabolic and genetic conditions, including galactosemia, phenylketonuria, sickle cell anemia, and congenital hypothyroidism. Additionally, screening exams encompass hearing tests, pulse oximetry, and blood testing, aiding in the early identification and management of issues affecting a baby’s normal growth and development.

Browse over XX market data Figures and spread through 110 Pages and an in-depth TOC on” Global Newborn Screening Market.” –

Recent Developments in Newborn Screening Facilities

In August 2022, Trivitron Healthcare inaugurated a center of excellence at the AMTZ Campus in Vishakhapatnam, showcasing cutting-edge R&D and production facilities. With esteemed personalities like Prof. Ajay Kumar Sood and Prof. (Dr.) Balram Bhargava attending the launch, this facility includes state-of-the-art laboratories for advanced genomics, molecular diagnostics, and protein chemistry. The objective is to internally produce raw ingredients and components for molecular diagnostics, Next Generation Sequencing (NGS), and Newborn Screening (NBS) using cutting-edge research methods.

Challenges in Market Penetration

Despite its growth, the global newborn screening market faces challenges rooted in public perception and stigma. Misconceptions or hesitancy among parents and caregivers regarding the purpose and benefits of newborn screening could impede its widespread acceptance. Concerns about stigmatization related to certain screened conditions, coupled with emotional challenges for parents receiving positive screening results, pose obstacles to universal adoption.

Market Segmentation

Based on Technology The market segmentation includes Tandem Mass Spectrometry, Pulse Oximetry, Enzyme-Based Assays, DNA Assays, and Other Technologies. Tandem Mass Spectrometry, for instance, is a powerful analytical technique used in various scientific fields, enabling detailed analysis and quantification of complex mixtures, proteins, peptides, and metabolites.

Based on Region North America currently dominates the global market due to its well-established healthcare infrastructure supporting comprehensive newborn screening programs. Conversely, the Asia-Pacific region exhibits the fastest growth, driven by its high birth rate, increasing healthcare awareness, and government initiatives to expand newborn screening services. Countries like China and India are investing significantly in healthcare infrastructure, catering to a burgeoning middle-class population seeking quality healthcare.

The global newborn screening market is poised for substantial growth, fueled by technological advancements, expanded screening panels, and increased healthcare awareness. However, challenges related to public perception and stigma need to be addressed for universal acceptance. With North America leading the current landscape and the Asia-Pacific region exhibiting rapid growth, strategic investments and initiatives are essential for sustained market expansion.

Some of the major companies operating in the Global Newborn Screening Market include:

  • Bio-Rad Laboratories Inc.
  • GE Healthcare
  • Masimo Corporation
  • Medtronic Inc.
  • Natus Medical Incorporated
  • PerkinElmer Inc.
  • Trivitron Healthcare
  • ZenTech SA
  • Demant A/S
  • Thermo Fisher Scientific
  • Hill-Rom Holdings Inc.

Download  Free Sample Report

Customers can also request 10% free customization on this report.

“Certain areas, particularly in North America, are projected to exert significant demand for Newborn Screening. The growth in the competitive landscape and the presence of well-established companies in the market, committed to enhance the overall wellbeing of people each year, are expected to contribute to a remarkable growth of the Global Newborn Screening Market in the forecast period,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based Global management consulting firm.

 Newborn Screening Market – Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Technology (Tandem Mass Spectrometry, Pulse Oximetry, Enzyme Based Assays, DNA Assays, and Other Technologies), By Test Type (Dried Blood Spot, Hearing Screening, Critical Congenital Heart Defect (CCHD), and Other Test Types), By End User (Hospitals, Diagnostic Centers, and Other End Users), and By Region, Competition evaluated the future growth potential of Global Newborn Screening  Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Newborn Screening Market.

Download  Free Sample Report –

Recently Published Report –

Newborn Screening Market

Invasive Fungal Infection Market

Precision Immuno-Oncology Market

Contact Techsci Research-

US –

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Germany –

S-01, 2.floor, Subbelrather Straße,

15a Cologne,

Germany 50823

Tel: +49 221 65058833

Email: [email protected]